Skip to main content

Special Access & Exemptions

PageCovers
Compassionate UseTPA Art. 9 para. 4; Swissmedic authorisation; patient eligibility; reporting
Hospital ExemptionTPA Art. 9 para. 2(a); in-house manufactured devices; notification to Swissmedic
Named-Patient AccessTPA Art. 36; individual import authorisation; documentation requirements
Clinical Investigation PathwaysClinO-MD; first-in-human; expanded access; compassionate use within trials
Disclaimer

AI-assisted navigation aid only. Always verify against official Swissmedic and Fedlex sources. Not legal or regulatory advice.